← FDA DRUG APPROVALS

FDA ANDA · ANDA077717

ONDANSETRON

Sponsor: NESHER PHARMS

APPLICATION
ANDA077717
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET, ORALLY DISINTEGRATING
MARKETING STATUS
Discontinued

Products

ONDANSETRONDiscontinued
ONDANSETRON 8MG · TABLET, ORALLY DISINTEGRATING · ORAL
ONDANSETRONDiscontinued
ONDANSETRON 4MG · TABLET, ORALLY DISINTEGRATING · ORAL

Approval history

2007-05-23OriginalTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →